Data as of Aug 29
| +0.44 / +0.38%|
The 16 analysts offering 12-month price forecasts for Valeant Pharmaceuticals International Inc have a median target of 162.50, with a high estimate of 180.00 and a low estimate of 128.00. The median estimate represents a +38.53% increase from the last price of 117.30.
The current consensus among 17 polled investment analysts is to Buy stock in Valeant Pharmaceuticals International Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.